NDUFS1 promotes malignant breast cancer behaviors through enhancement of mitochondrial respiration and PROX1/c-Myc signaling
Abstract
Cancer cells exploit oxidative phosphorylation (OXPHOS) for growth and metastasis. NDUFS1, the largest subunit of the electron transport chain complex I, is a promising therapeutic target in cancer but has a context-dependent role. Here, we elucidate the function of NDUFS1 in breast cancer. Elevated NDUFS1 expression was associated with advanced breast cancer stage and poor survival outcomes. In vitro experiments showed that NDUFS1 knockdown inhibited breast cancer cell proliferation, invasion, and stemness-associated properties, whereas NDUFS1 overexpression enhanced these phenotypes. Moreover, NDUFS1 directly regulated mitochondrial respiratory function in breast cancer cells and increased c-Myc expression via PROX1. In a mouse model of breast cancer, NDUFS1 knockdown in injected mammary carcinoma cells or OXPHOS inhibition decreased tumor growth and PROX1 and c-Myc expression. Our study highlights the role of the NDUFS1-PROX1-c-Myc axis in breast cancer progression, paving the way for new therapies targeting breast cancer mitochondrial OXPHOS.
Related
- Role of podoplanin in tongue squamous cell carcinoma and the regulation of malignant cellular behaviors via the ERK/MMP-2 signaling axis
- Cancer cells differentially modulate mitochondrial respiration to alter redox state and enable biomass synthesis in nutrient-limited environments
- Acute and prolonged effects of anti-malarial drugs on mitochondrial respiration in atrial cardiomyocytes for cardiac safety evaluation
- Altered Peripheral Blood Mononuclear Cell (PBMC) Mitochondrial Coupling and Complex IV Respiration in Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement (TAVR).
- A “Progenitor Cell Ark” hydrogel system for intervertebral disc regeneration via mitochondrial targeting and mitophagy enhancement
BibTeX
@article{wang2026ndufs1,
title = {{NDUFS1 promotes malignant breast cancer behaviors through enhancement of mitochondrial respiration and PROX1/c-Myc signaling}},
author = {Yen-Yun Wang and Pang-Yu Chen and Lester Uy Vinzons and Chih-Huang Tseng and Yuk-Kwan Chen and Stephen Chu-Sung Hu and Steven Lo and Ming-Feng Hou and Ching-Hu Wu and Yu-Chieh Chen and Shyng-Shiou F. Yuan},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117942},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03325-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - NDUFS1 promotes malignant breast cancer behaviors through enhancement of mitochondrial respiration and PROX1/c-Myc signaling
AU - Yen-Yun Wang
AU - Pang-Yu Chen
AU - Lester Uy Vinzons
AU - Chih-Huang Tseng
AU - Yuk-Kwan Chen
AU - Stephen Chu-Sung Hu
AU - Steven Lo
AU - Ming-Feng Hou
AU - Ching-Hu Wu
AU - Yu-Chieh Chen
AU - Shyng-Shiou F. Yuan
PY - 2026
DA - 2026/10/19
JO - iScience
DO - 10.1016/j.isci.2026.117942
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03325-0
AB - Cancer cells exploit oxidative phosphorylation (OXPHOS) for growth and metastasis. NDUFS1, the largest subunit of the electron transport chain complex I, is a promising therapeutic target in cancer but has a context-dependent role. Here, we elucidate the function of NDUFS1 in breast cancer. Elevated NDUFS1 expression was associated with advanced breast cancer stage and poor survival outcomes. In vitro experiments showed that NDUFS1 knockdown inhibited breast cancer cell proliferation, invasion, and stemness-associated properties, whereas NDUFS1 overexpression enhanced these phenotypes. Moreover, NDUFS1 directly regulated mitochondrial respiratory function in breast cancer cells and increased c-Myc expression via PROX1. In a mouse model of breast cancer, NDUFS1 knockdown in injected mammary carcinoma cells or OXPHOS inhibition decreased tumor growth and PROX1 and c-Myc expression. Our study highlights the role of the NDUFS1-PROX1-c-Myc axis in breast cancer progression, paving the way for new therapies targeting breast cancer mitochondrial OXPHOS.
SN - 2589-0042
ER -